450 related articles for article (PubMed ID: 21871538)
1. A mitochondrial etiology of Alzheimer and Parkinson disease.
Coskun P; Wyrembak J; Schriner SE; Chen HW; Marciniack C; Laferla F; Wallace DC
Biochim Biophys Acta; 2012 May; 1820(5):553-64. PubMed ID: 21871538
[TBL] [Abstract][Full Text] [Related]
2. Systemic mitochondrial dysfunction and the etiology of Alzheimer's disease and down syndrome dementia.
Coskun PE; Wyrembak J; Derbereva O; Melkonian G; Doran E; Lott IT; Head E; Cotman CW; Wallace DC
J Alzheimers Dis; 2010; 20 Suppl 2(0 2):S293-310. PubMed ID: 20463402
[TBL] [Abstract][Full Text] [Related]
3. Mitochondrial defects and oxidative stress in Alzheimer disease and Parkinson disease.
Yan MH; Wang X; Zhu X
Free Radic Biol Med; 2013 Sep; 62():90-101. PubMed ID: 23200807
[TBL] [Abstract][Full Text] [Related]
4. A mitochondrial etiology of neurodegenerative diseases: evidence from Parkinson's disease.
Khusnutdinova E; Gilyazova I; Ruiz-Pesini E; Derbeneva O; Khusainova R; Khidiyatova I; Magzhanov R; Wallace DC
Ann N Y Acad Sci; 2008 Dec; 1147():1-20. PubMed ID: 19076426
[TBL] [Abstract][Full Text] [Related]
5. No evidence of association between common European mitochondrial DNA variants in Alzheimer, Parkinson, and migraine in the Spanish population.
Fachal L; Mosquera-Miguel A; Pastor P; Ortega-Cubero S; Lorenzo E; Oterino-Durán A; Toriello M; Quintáns B; Camiña-Tato M; Sesar A; Vega A; Sobrido MJ; Salas A
Am J Med Genet B Neuropsychiatr Genet; 2015 Jan; 168B(1):54-65. PubMed ID: 25349034
[TBL] [Abstract][Full Text] [Related]
6. Mitochondria in the pathophysiology of Alzheimer's and Parkinson's diseases.
Onyango IG; Khan SM; Bennett JP
Front Biosci (Landmark Ed); 2017 Jan; 22(5):854-872. PubMed ID: 27814651
[TBL] [Abstract][Full Text] [Related]
7. Hypermethylation of Mitochondrial Cytochrome b and Cytochrome c Oxidase II Genes with Decreased Mitochondrial DNA Copy Numbers in the APP/PS1 Transgenic Mouse Model of Alzheimer's Disease.
Xu Y; Cheng L; Sun J; Li F; Liu X; Wei Y; Han M; Zhu Z; Bi J; Lai C; Wang Y
Neurochem Res; 2021 Mar; 46(3):564-572. PubMed ID: 33580369
[TBL] [Abstract][Full Text] [Related]
8. Metabolic and Growth Rate Alterations in Lymphoblastic Cell Lines Discriminate Between Down Syndrome and Alzheimer's Disease.
Coskun P; Helguera P; Nemati Z; Bohannan RC; Thomas J; Samuel SE; Argueta J; Doran E; Wallace DC; Lott IT; Busciglio J
J Alzheimers Dis; 2017; 55(2):737-748. PubMed ID: 27802222
[TBL] [Abstract][Full Text] [Related]
9. Abnormal interaction of VDAC1 with amyloid beta and phosphorylated tau causes mitochondrial dysfunction in Alzheimer's disease.
Manczak M; Reddy PH
Hum Mol Genet; 2012 Dec; 21(23):5131-46. PubMed ID: 22926141
[TBL] [Abstract][Full Text] [Related]
10. Evidence for sub-haplogroup h5 of mitochondrial DNA as a risk factor for late onset Alzheimer's disease.
Santoro A; Balbi V; Balducci E; Pirazzini C; Rosini F; Tavano F; Achilli A; Siviero P; Minicuci N; Bellavista E; Mishto M; Salvioli S; Marchegiani F; Cardelli M; Olivieri F; Nacmias B; Chiamenti AM; Benussi L; Ghidoni R; Rose G; Gabelli C; Binetti G; Sorbi S; Crepaldi G; Passarino G; Torroni A; Franceschi C
PLoS One; 2010 Aug; 5(8):e12037. PubMed ID: 20700462
[TBL] [Abstract][Full Text] [Related]
11. Abnormal mitochondrial morphology in sporadic Parkinson's and Alzheimer's disease cybrid cell lines.
Trimmer PA; Swerdlow RH; Parks JK; Keeney P; Bennett JP; Miller SW; Davis RE; Parker WD
Exp Neurol; 2000 Mar; 162(1):37-50. PubMed ID: 10716887
[TBL] [Abstract][Full Text] [Related]
12. Mitochondrial biogenesis: pharmacological approaches.
Valero T
Curr Pharm Des; 2014; 20(35):5507-9. PubMed ID: 24606795
[TBL] [Abstract][Full Text] [Related]
13. Alzheimer's brains harbor somatic mtDNA control-region mutations that suppress mitochondrial transcription and replication.
Coskun PE; Beal MF; Wallace DC
Proc Natl Acad Sci U S A; 2004 Jul; 101(29):10726-31. PubMed ID: 15247418
[TBL] [Abstract][Full Text] [Related]
14. Mitochondria, mitochondrial DNA and Alzheimer's disease. What comes first?
Mancuso M; Orsucci D; Siciliano G; Murri L
Curr Alzheimer Res; 2008 Oct; 5(5):457-68. PubMed ID: 18855587
[TBL] [Abstract][Full Text] [Related]
15. Intermittent Hypoxic Conditioning Rescues Cognition and Mitochondrial Bioenergetic Profile in the Triple Transgenic Mouse Model of Alzheimer's Disease.
Correia SC; Machado NJ; Alves MG; Oliveira PF; Moreira PI
Int J Mol Sci; 2021 Jan; 22(1):. PubMed ID: 33466445
[TBL] [Abstract][Full Text] [Related]
16. The role of mitochondrial disturbances in Alzheimer, Parkinson and Huntington diseases.
Carvalho C; Correia SC; Cardoso S; Plácido AI; Candeias E; Duarte AI; Moreira PI
Expert Rev Neurother; 2015; 15(8):867-84. PubMed ID: 26092668
[TBL] [Abstract][Full Text] [Related]
17. Mitochondrial DNA deletions/rearrangements in parkinson disease and related neurodegenerative disorders.
Gu G; Reyes PE; Golden GT; Woltjer RL; Hulette C; Montine TJ; Zhang J
J Neuropathol Exp Neurol; 2002 Jul; 61(7):634-9. PubMed ID: 12125742
[TBL] [Abstract][Full Text] [Related]
18. Biocomplexity and Fractality in the Search of Biomarkers of Aging and Pathology: Mitochondrial DNA Profiling of Parkinson's Disease.
Zaia A; Maponi P; Zannotti M; Casoli T
Int J Mol Sci; 2020 Mar; 21(5):. PubMed ID: 32143500
[TBL] [Abstract][Full Text] [Related]
19. Etiology and pathophysiology of frontotemporal dementia, Parkinson disease and Alzheimer disease: lessons from genetic studies.
Wider C; Wszolek ZK
Neurodegener Dis; 2008; 5(3-4):122-5. PubMed ID: 18322368
[TBL] [Abstract][Full Text] [Related]
20. mtDNA mutations and common neurodegenerative disorders.
Howell N; Elson JL; Chinnery PF; Turnbull DM
Trends Genet; 2005 Nov; 21(11):583-6. PubMed ID: 16154228
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
